Jeff Geschwind, MD: Founder of Cage Pharma Jeff Geschwind, MD, founded Cage Pharma (formerly PreScience Labs) to develop cancer drugs targeting tumor metabolism. His research focuses on glycolysis inhibition, a novel approach to starving aggressive tumors. https://www.linkedin.com/in/jeff-geschwind-037200174